{"id":"doi:10.1080/14737175.2016.1220834","kind":"review","title":"Psilocybin for treating substance use disorders?","authors":["Bas T.H. de Veen","Arnt Schellekens","Michel M. M. Verheij","Judith Regina Homberg"],"author_count":4,"year":2016,"published":"2016-08-10","venue":"Expert Review of Neurotherapeutics","cited_by":99,"doi":"10.1080/14737175.2016.1220834","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1080/14737175.2016.1220834","archive_url":"https://space-kitty.com/papers/doi:10.1080/14737175.2016.1220834","updated":null,"pmid":"27684102","pmcid":null,"openalex_id":"W2499216663","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14737175.2016.1220834?needAccess=true","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Psychedelics and Drug Studies"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"psychiatric-therapeutics","name":"Novel Psychiatric Therapeutics","domain_slug":"neuroscience"}],"cited_in_dossiers":[]}